← All Zai Lab LTD filings

Zai Lab LTD DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ZLAB
Zai Lab LTD
DEF: Zai Lab Announces 2026 Annual Meeting Details
Zai Lab Limited has issued its proxy statement for the 2026 Annual General Meeting of Shareholders, detailing proposals for director re-elections, auditor appointments, and share mandates.
NASDAQ
ZLAB
Zai Lab LTD
DEFA14A: Zai Lab Limited Files Definitive Proxy Statement with SEC
Zai Lab Limited has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
ZLAB
Zai Lab LTD
DEF: Zai Lab Limited Seeks Shareholder Approval for Director Re-elections, Auditor Appointment, and Share Issuance/Repurchase Mandates at 2025 Annual Meeting
Zai Lab Limited is holding its 2025 Annual General Meeting of Shareholders on June 18, 2025, to vote on the re-election of directors, appointment of auditors, executive compensation, and mandates for share issuance and repurchase.
NASDAQ
ZLAB
Zai Lab LTD
DEFA14A: Zai Lab Limited Files Definitive Proxy Statement with SEC
Zai Lab Limited has filed a definitive proxy statement with the U.S. Securities and Exchange Commission.
NASDAQ
ZLAB
Zai Lab LTD
DEF 14A: Zai Lab Seeks Shareholder Approval for Director Re-elections, Auditor Appointment, Executive Compensation, and Equity Incentive Plan
Zai Lab is holding its 2024 Annual General Meeting to vote on key proposals including director re-elections, auditor appointments, executive compensation, and a new equity incentive plan.